This tender is from the country of Germany in Europe region. The tender was published by AOK Bremen Bremerhaven on 06 Nov 2025 for Ranibizumab atc code s01la04 In the open house procedure medicines according to the BfArM list according to Section 35 Para 5a SGB V children s medicines are excluded The subject of this publication is the conclusion of contracts in accordance with Section 130a Paragraph 8 SGB V for various active ingredients as part of a so-called open house procedure Subject to uniform contractual conditions and a uniform access procedure all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the named active ingredient The earliest contract start date is December 1st 2025 and the contract end date is December 31st 2025 Joining this open house process is possible at any time within the contract period If you are interested please be so kind as to send us the discount agreement signed in duplicate by email in advance taking into account the BfArM children s medicine list. The last date to submit your bid for this tender is 04 Nov 2027. This tender is for the companies specializing in Pharmaceutical products and similar sectors.
Tender Organisation:
AOK Bremen Bremerhaven
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33600000 : Pharmaceutical products
Tender Document Type:
Tender Notice
Tender Description:
Ranibizumab atc code s01la04 In the open house procedure medicines according to the BfArM list according to Section 35 Para 5a SGB V children s medicines are excluded The subject of this publication is the conclusion of contracts in accordance with Section 130a Paragraph 8 SGB V for various active ingredients as part of a so-called open house procedure Subject to uniform contractual conditions and a uniform access procedure all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the opportunity to conclude or join a discount agreement in accordance with Section 130a Paragraph 8 SGB V for the named active ingredient The earliest contract start date is December 1st 2025 and the contract end date is December 31st 2025 Joining this open house process is possible at any time within the contract period If you are interested please be so kind as to send us the discount agreement signed in duplicate by email in advance taking into account the BfArM children s medicine list
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in Pharmaceutical products? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Healthcare & Medical sector in Germany, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Germany is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33600000, enabling precise filtering. Search by:
While you're viewing a tender in Germany, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Healthcare & Medical, Germany, and Pharmaceutical products categories.